Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers

Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers

Bibliographic Details
Main Author:	Yingyan Yu
Format:	Article
Language:	English
Published:	China Anti-Cancer Association 2021-11-01
Series:	Cancer Biology & Medicine
Online Access:	http://www.cancerbiomed.org/index.php/cocr/article/view/1961

Similar Items

Repurposing drugs for solid tumor treatment: focus on immune checkpoint inhibitors
by: Qingxu Liu, et al.
Published: (2023-11-01)

Drug Repurposing to Circumvent Immune Checkpoint Inhibitor Resistance in Cancer Immunotherapy
by: Kenneth K. W. To, et al.
Published: (2023-08-01)

The effects of glucocorticoids and immunosuppressants on cancer outcomes in checkpoint inhibitor therapy
by: Sebastian Bruera, et al.
Published: (2022-08-01)

Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant Oncology
by: Karen Abboud, et al.
Published: (2023-02-01)

ICU admission for solid cancer patients treated with immune checkpoint inhibitors
by: Anne-Claire Toffart, et al.
Published: (2023-04-01)

Immune Checkpoint Inhibitors and Other Immune Therapies in Breast Cancer: A New Paradigm for Prolonged Adjuvant Immunotherapy
by: Andrea Nicolini, et al.
Published: (2022-10-01)

Impact of endogenous glucocorticoid on response to immune checkpoint blockade in patients with advanced cancer
by: Yu Cui, et al.
Published: (2023-04-01)

Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint Inhibitors
by: Xavier Thuru, et al.
Published: (2022-07-01)

Effects of glucocorticoid use on survival of advanced non-small-cell lung cancer patients treated with immune checkpoint inhibitors
by: Nijiao Li, et al.
Published: (2023-11-01)

Immune Thrombocytopenia Induced by Immune Checkpoint Inhibitors in Solid Cancer: Case Report and Literature Review
by: Xiaolin Liu, et al.
Published: (2020-12-01)

Drug Repurposing to Treat Glucocorticoid Resistance in Asthma
by: Alberta L. Wang, et al.
Published: (2021-03-01)

Increasing cure rates of solid tumors by immune checkpoint inhibitors
by: Weijie Ma, et al.
Published: (2023-01-01)

Immune Checkpoint Inhibitors in Prostate Cancer
by: Shobi Venkatachalam, et al.
Published: (2021-05-01)

Immune Checkpoint Inhibitors in Cancer Therapy
by: Yavar Shiravand, et al.
Published: (2022-04-01)

Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review
by: Biagio Barone, et al.
Published: (2022-05-01)

Repurposing pentamidine for cancer immunotherapy by targeting the PD1/PD-L1 immune checkpoint
by: Tingxuan Gu, et al.
Published: (2023-05-01)

Clinical Potential of Kinase Inhibitors in Combination with Immune Checkpoint Inhibitors for the Treatment of Solid Tumors
by: Ryuhjin Ahn, et al.
Published: (2021-03-01)

Clinical Potential of Kinase Inhibitors in Combination with Immune Checkpoint Inhibitors for the Treatment of Solid Tumors
by: Ahn, Ryuhjin, et al.
Published: (2021)

Deaths and adverse events from adjuvant therapy with immune checkpoint inhibitors in solid malignant tumors: A systematic review and network meta‐analysis
by: Ruiyang Xie, et al.
Published: (2022-12-01)

Immune checkpoint inhibitors for solid organ transplant recipients: clinical updates
by: Shun Kawashima, et al.
Published: (2022-06-01)

How Can Immune Checkpoint Inhibitors Cause Hyperprogression in Solid Tumors?
by: Morgane Denis, et al.
Published: (2020-03-01)

Retreatment with immune checkpoint inhibitors in solid tumors: a systematic review
by: Kaili Yang, et al.
Published: (2020-11-01)

Clinical Application of Immune Checkpoint Inhibitors CTLA-4 in Solid Tumors
by: LI Tao, et al.
Published: (2023-05-01)

Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine
by: Lu Lu, et al.
Published: (2020-12-01)

Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta‐analysis
by: Yukinori Takenaka, et al.
Published: (2021-10-01)

Safety of COVID-19 vaccines in subjects with solid tumor cancers receiving immune checkpoint inhibitors
by: Danielle Gilbert, et al.
Published: (2023-01-01)

Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
by: Antonio Lopez-Beltran, et al.
Published: (2021-01-01)

Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy
by: Juwon Lee, et al.
Published: (2021-07-01)

The Role of Immune Checkpoint Inhibitors in Cancer Therapy
by: Ahmed M. Basudan
Published: (2022-12-01)

Resistance to immune checkpoint inhibitors in gastric cancer
by: Kai Liu, et al.
Published: (2023-11-01)

Role of immune-checkpoint inhibitors in lung cancer
by: Prantesh Jain, et al.
Published: (2018-01-01)

The role of immune checkpoint inhibitors in prostate cancer
by: Gabriel Surdacki, et al.
Published: (2019-03-01)

An overview of immune checkpoint inhibitors in breast cancer
by: Federica Miglietta, et al.
Published: (2020-12-01)

Prevalence of PRKDC mutations and association with response to immune checkpoint inhibitors in solid tumors
by: Yu Chen, et al.
Published: (2020-09-01)

Bibliometric analysis of research trends on the combination of immune checkpoint inhibitors and PARP inhibitors in solid tumors
by: Yaqian Tan, et al.
Published: (2024-01-01)

B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors
by: Jean-Yves Scoazec, et al.
Published: (2024-04-01)

Tumor Genotype Is Shaping Immunophenotype and Responses to Immune Checkpoint Inhibitors in Solid Tumors
by: Kathrina L. Marcelo-Lewis, et al.
Published: (2020-08-01)

Immune Checkpoint Inhibitors and the Heart
by: Diana Larisa Mocan-Hognogi, et al.
Published: (2021-09-01)

Application of Immune Checkpoint Inhibitors in Gynecological Cancers: What Do Gynecologists Need to Know before Using Immune Checkpoint Inhibitors?
by: Seon-Mi Lee, et al.
Published: (2023-01-01)

Immune-Checkpoint Inhibitors in Platinum-Resistant Ovarian Cancer
by: Alice Indini, et al.
Published: (2021-04-01)